• Award recipients to receive in-kind technologies and services to accelerate therapeutics to market
• Merck experts to provide consultation and training in qualification, risk assessment, and process optimization
• Program extended this year to Australia, New Zealand, Taiwan, South Korea

SINGAPORE - Media OutReach Newswire - 1 November 2024 - Merck, a leading science and technology company, today announced the winners of its Emerging Biotech (EB) Grant Program in Asia Pacific.